multiple sclerosis prolonged administration study efficacy single oral doses motor visual signs multiple sclerosis MS patients mean hours efficacy multiple daily doses several days mg temperature-sensitive MS patients daily doses intervals days double-blind study Nine patients placebo Thirteen patients important motor visual improvements placebo group Average peak improvement scores placebo Seventy percent daily improvements hours improvements consecutive doses mean hours average treatment-observation period hours placebo average treatment-observation period serious side effects promising drug symptomatic treatment MS 